Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
ABIO Stock Trend
The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.24 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift.
Given the current short-term trend, the stock is expected to rise 10.3% during the next 3 months and, with a 90% probability hold a price between $2.47 and $2.95 at the end of this 3-month period.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-25 | $2.24 | $2.46 | $2.68 |
| 2022-05-26 | $2.25 | $2.46 | $2.68 |
| 2022-05-27 | $2.25 | $2.47 | $2.69 |
| 2022-05-31 | $2.25 | $2.47 | $2.69 |
| 2022-06-01 | $2.26 | $2.48 | $2.69 |
| 2022-06-02 | $2.26 | $2.48 | $2.70 |
| 2022-06-03 | $2.27 | $2.48 | $2.70 |
| 2022-06-06 | $2.27 | $2.49 | $2.71 |
| 2022-06-07 | $2.27 | $2.49 | $2.71 |
| 2022-06-08 | $2.28 | $2.50 | $2.72 |
| 2022-06-09 | $2.28 | $2.50 | $2.72 |
| 2022-06-10 | $2.29 | $2.50 | $2.72 |
| 2022-06-13 | $2.29 | $2.51 | $2.73 |
| 2022-06-14 | $2.29 | $2.51 | $2.73 |
| 2022-06-15 | $2.30 | $2.52 | $2.74 |
| 2022-06-16 | $2.30 | $2.52 | $2.74 |
| 2022-06-17 | $2.31 | $2.53 | $2.74 |
| 2022-06-21 | $2.31 | $2.53 | $2.75 |
| 2022-06-22 | $2.32 | $2.53 | $2.75 |
| 2022-06-23 | $2.32 | $2.54 | $2.76 |
| 2022-06-24 | $2.32 | $2.54 | $2.76 |
| 2022-06-27 | $2.33 | $2.55 | $2.76 |
| 2022-06-28 | $2.33 | $2.55 | $2.77 |
| 2022-06-29 | $2.34 | $2.55 | $2.77 |
| 2022-06-30 | $2.34 | $2.56 | $2.78 |
| 2022-07-01 | $2.34 | $2.56 | $2.78 |
| 2022-07-05 | $2.35 | $2.57 | $2.78 |
| 2022-07-06 | $2.35 | $2.57 | $2.79 |
| 2022-07-07 | $2.36 | $2.57 | $2.79 |
| 2022-07-08 | $2.36 | $2.58 | $2.80 |
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator, which is in clinical trial for the treatment of atrial fibrillation in patients with heart failure and left ventricular with reduced left ventricular ejection fraction. The company also engages in developing recombinant Nem... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
